Case Updates
Second Circuit holds that manufacturers are not prohibited from adding supplemental warnings to drug labels under the Pregnancy Warning Regulation
July 13, 2026
U.S. Chamber files amicus brief urging Second Circuit to hold that plaintiffs’ state-law claims are preempted by federal law, which does not permit state-by-state supplemental pregnancy warnings on over the counter drug labels that must include the FDA’s general pregnancy warning
November 14, 2024
Joshua J. Fougere and Madeleine Joseph of Sidley Austin LLP served as outside counsel.